Mollevi, C.
59  Ergebnisse:
Personensuche X
?
2

Étude d'impact d'un parcours de soins entre la médecine de ..:

Bitard, J. ; Boutin, C. ; Mollevi, C..
La Revue de Médecine Interne.  44 (2023)  - p. A122-A123 , 2023
 
?
3

P11.19.B Bevacizumab in recurrent WHO grade 2-3 gliomas:

Annakib, S ; Rigau, V ; Darlix, A...
Neuro-Oncology.  24 (2022)  Supplement_2 - p. ii60-ii60 , 2022
 
?
6

Handling informative dropout in longitudinal analysis of he..:

Cuer, B. ; Mollevi, C. ; Anota, A....
BMC Medical Research Methodology.  20 (2020)  1 - p. , 2020
 
?
7

GUIP1: a R package for dose escalation strategies in phase ..:

Dinart, D. ; Fraisse, J. ; Tosi, D....
BMC Medical Informatics and Decision Making.  20 (2020)  1 - p. , 2020
 
?
8

Antibody targeting of claudin-1 as a potential colorectal c..:

Cherradi, S. ; Ayrolles-Torro, A. ; Vezzo-Vié, N....
Journal of Experimental & Clinical Cancer Research.  36 (2017)  1 - p. , 2017
 
?
 
?
10

The anti-leukemic drug nilotinib inhibits metastatic proper..:

Tosti, P. ; Leroy, C. ; Jeitany, M....
European Journal of Cancer.  61 (2016)  - p. S148-S149 , 2016
 
?
 
?
12

1402 POSTER DISCUSSION CT Evaluation of the Response of Col..:

Mazard, T. ; Assenat, E. ; Ychou, M....
European Journal of Cancer.  47 (2011)  - p. S169-S170 , 2011
 
?
13

513 POSTER Anti-tumor effect of an anti-human Müllerian Inh..:

Kersual, N. ; Garambois, V. ; Salhi, I....
European Journal of Cancer Supplements.  6 (2008)  12 - p. 163 , 2008
 
?
14

541 POSTER Gemcitabine versus combined antibodies against E..:

Larbouret, C. ; Robert, B. ; Mollevi, C....
European Journal of Cancer Supplements.  6 (2008)  12 - p. 171 , 2008
 
?
15

602 POSTER An anti-idiotypic HER2 vaccine can reverse immun..:

Ladjemi, M.Z. ; Corgnac, S. ; Morisseau, S....
European Journal of Cancer Supplements.  6 (2008)  12 - p. 188 , 2008
 
1-15